InvestorsHub Logo
icon url

Jhawker

02/03/21 4:37 PM

#343621 RE: To infinity and beyond! #343612

The bar for good therapeutics for covid are very low and how many therapeutics do you know have the extensive preclinical success that B has had?
icon url

LIVED

02/03/21 4:43 PM

#343622 RE: To infinity and beyond! #343612

he does not have a strong opinion about trial success. Neither do I.

Dr. this is what you stated in a reply: Their advisers are experts. I just see emergency patients.
icon url

williamssc

02/03/21 5:20 PM

#343632 RE: To infinity and beyond! #343612

Brilacidin performed excellent in our IPIX human trial for the treatment of acute bacterial skin and skin structure infections. One IV treatment was all that was needed for B to pierce the bacterial wall and kill the disease. MOA is the same... piercing the viral wall. Yes trial could fail, be mediocre or be a huge success. I like to think our absssi trial is a indicator of success. We shall soon see.